Corcept Therapeutics CORT Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Corcept Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Corcept Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corcept Therapeutics's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corcept Therapeutics's net income?
- Corcept Therapeutics (CORT) reported net income of -$31.76M in Q1 2026.
- How has Corcept Therapeutics's net income changed year-over-year?
- Corcept Therapeutics's net income decreased by 254.6% year-over-year, from $20.55M to -$31.76M.
- What is the long-term trend for Corcept Therapeutics's net income?
- Over 4 years (2021 to 2025), Corcept Therapeutics's net income has grown at a -3.0% compound annual growth rate (CAGR), from $112.51M to $99.65M.
- What does net income mean?
- The actual profit a company keeps after all expenses and taxes are paid.
- How do you interpret net income?
- A positive and growing net income is the primary indicator of long-term financial viability and shareholder value creation.
- How does net income compare across companies?
- The most common metric for assessing overall company performance and valuation multiples.